Kingworld Medicines (01110) Announces February 2026 Monthly Return
Bulletin Express
Mar 02
Kingworld Medicines Group Limited (stock code: 01110) released its monthly return for February 2026. According to the announcement, the authorized share capital remained at 10,000,000,000 ordinary shares with a par value of HKD 0.10 each, totaling HKD 1.00 billion.
The issued share capital stood at 622.50 million ordinary shares, showing no change from the previous month. The company confirmed that it satisfied the applicable public float requirement as of February 28, 2026, with no new share options, warrants, convertibles, or other relevant agreements disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.